646 related articles for article (PubMed ID: 25651247)
21. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
[TBL] [Abstract][Full Text] [Related]
22. The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients.
Bechler K; Shkirkova K; Saver JL; Starkman S; Hamilton S; Liebeskind DS; Eckstein M; Stratton S; Pratt F; Conwit R; Sanossian N
Cardiovasc Ther; 2020; 2020():1494506. PubMed ID: 33072188
[TBL] [Abstract][Full Text] [Related]
23. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
[TBL] [Abstract][Full Text] [Related]
24. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.
Wong GK; Poon WS; Chan MT; Boet R; Gin T; Ng SC; Zee BC;
Stroke; 2010 May; 41(5):921-6. PubMed ID: 20378868
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the intravenous magnesium sulfate effect in clinical improvement of patients with acute ischemic stroke.
Afshari D; Moradian N; Rezaei M
Clin Neurol Neurosurg; 2013 Apr; 115(4):400-4. PubMed ID: 22749947
[TBL] [Abstract][Full Text] [Related]
26. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Baxter BW; Devlin TG; Lopes DK; Reddy VK; du Mesnil de Rochemont R; Singer OC; Jahan R;
N Engl J Med; 2015 Jun; 372(24):2285-95. PubMed ID: 25882376
[TBL] [Abstract][Full Text] [Related]
27. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
[TBL] [Abstract][Full Text] [Related]
28. Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial.
Liu X; Wang L; Wen A; Yang J; Yan Y; Song Y; Liu X; Ren H; Wu Y; Li Z; Chen W; Xu Y; Li L; Xia J; Zhao G
Eur J Neurol; 2012 Jun; 19(6):855-63. PubMed ID: 22233205
[TBL] [Abstract][Full Text] [Related]
29. Field Validation of the Los Angeles Motor Scale as a Tool for Paramedic Assessment of Stroke Severity.
Kim JT; Chung PW; Starkman S; Sanossian N; Stratton SJ; Eckstein M; Pratt FD; Conwit R; Liebeskind DS; Sharma L; Restrepo L; Tenser MK; Valdes-Sueiras M; Gornbein J; Hamilton S; Saver JL;
Stroke; 2017 Feb; 48(2):298-306. PubMed ID: 28087807
[TBL] [Abstract][Full Text] [Related]
30. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
Grotta J
Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
[TBL] [Abstract][Full Text] [Related]
31. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W;
Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739
[TBL] [Abstract][Full Text] [Related]
32. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
[TBL] [Abstract][Full Text] [Related]
33. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
Bain ES; Middleton PF; Yelland LN; Ashwood PJ; Crowther CA
BJOG; 2014 Apr; 121(5):595-603. PubMed ID: 24387624
[TBL] [Abstract][Full Text] [Related]
34. Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage.
Takeuchi S; Kumagai K; Toyooka T; Otani N; Wada K; Mori K
Stroke; 2021 Jan; 52(1):20-27. PubMed ID: 33349011
[TBL] [Abstract][Full Text] [Related]
35. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
Diener HC
Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
[TBL] [Abstract][Full Text] [Related]
36. Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study.
Lampl Y; Gilad R; Geva D; Eshel Y; Sadeh M
Clin Neuropharmacol; 2001; 24(1):11-5. PubMed ID: 11290876
[TBL] [Abstract][Full Text] [Related]
37. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
[TBL] [Abstract][Full Text] [Related]
38. Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke.
Anderson CS; Arima H; Lavados P; Billot L; Hackett ML; Olavarría VV; Muñoz Venturelli P; Brunser A; Peng B; Cui L; Song L; Rogers K; Middleton S; Lim JY; Forshaw D; Lightbody CE; Woodward M; Pontes-Neto O; De Silva HA; Lin RT; Lee TH; Pandian JD; Mead GE; Robinson T; Watkins C;
N Engl J Med; 2017 Jun; 376(25):2437-2447. PubMed ID: 28636854
[TBL] [Abstract][Full Text] [Related]
39. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
Albers GW; Goldstein LB; Hall D; Lesko LM;
JAMA; 2001 Dec; 286(21):2673-82. PubMed ID: 11730442
[TBL] [Abstract][Full Text] [Related]
40. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.
Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators
Stroke; 2005 Apr; 36(4):880-90. PubMed ID: 15731473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
